| Resveratrol delays age-related deterioration and mimics transcriptional aspects of dietary restriction without extending life span KJ Pearson, JA Baur, KN Lewis, L Peshkin, NL Price, N Labinskyy, ... Cell metabolism 8 (2), 157-168, 2008 | 1409 | 2008 |
| Defective fatty acid oxidation in renal tubular epithelial cells has a key role in kidney fibrosis development HM Kang, SH Ahn, P Choi, YA Ko, SH Han, F Chinga, ASD Park, J Tao, ... Nature medicine 21 (1), 37-46, 2015 | 1366 | 2015 |
| Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth … FN Ziyadeh, BB Hoffman, DC Han, MC Iglesias-De la Cruz, SW Hong, ... Proceedings of the National Academy of Sciences 97 (14), 8015-8020, 2000 | 1183 | 2000 |
| Diabetic kidney disease MC Thomas, M Brownlee, K Susztak, K Sharma, KAM Jandeleit-Dahm, ... Nature reviews Disease primers 1 (1), 1-20, 2015 | 1101 | 2015 |
| The NASA Twins Study: A multidimensional analysis of a year-long human spaceflight FE Garrett-Bakelman, M Darshi, SJ Green, RC Gur, L Lin, BR Macias, ... Science 364 (6436), eaau8650, 2019 | 1027 | 2019 |
| Neutralization of TGF-β by anti-TGF-β antibody attenuates kidney hypertrophy and the enhanced extracellular matrix gene expression in STZ-induced diabetic mice K Sharma, Y Jin, J Guo, FN Ziyadeh Diabetes 45 (4), 522-530, 1996 | 912 | 1996 |
| Adiponectin regulates albuminuria and podocyte function in mice K Sharma, S RamachandraRao, G Qiu, HK Usui, Y Zhu, SR Dunn, ... The Journal of clinical investigation 118 (5), 1645-1656, 2008 | 821 | 2008 |
| Hyperglycemia and diabetic kidney disease: The case for transforming growth factor–β as a key mediator K Sharma, FN Ziyadeh Diabetes 44 (10), 1139-1146, 1995 | 813 | 1995 |
| Stimulation of collagen gene expression and protein synthesis in murine mesangial cells by high glucose is mediated by autocrine activation of transforming growth factor-beta. FN Ziyadeh, K Sharma, M Ericksen, G Wolf The Journal of clinical investigation 93 (2), 536-542, 1994 | 780 | 1994 |
| Mouse models of diabetic nephropathy MD Breyer, E Bo, FC Brosius III, TM Coffman, RC Harris, CW Heilig, ... Journal of the American Society of Nephrology 16 (1), 27-45, 2005 | 674 | 2005 |
| Diabetic kidney disease in the db/dbmouse K Sharma, P McCue, SR Dunn American Journal of Physiology-Renal Physiology 284 (6), F1138-F1144, 2003 | 666 | 2003 |
| Mouse models of diabetic nephropathy FC Brosius III, CE Alpers, EP Bottinger, MD Breyer, TM Coffman, ... Journal of the American Society of Nephrology 20 (12), 2503-2512, 2009 | 617 | 2009 |
| Metabolomics reveals signature of mitochondrial dysfunction in diabetic kidney disease K Sharma, B Karl, AV Mathew, JA Gangoiti, CL Wassel, R Saito, M Pu, ... Journal of the American Society of Nephrology 24 (11), 1901-1912, 2013 | 582 | 2013 |
| Development of a definition of postacute sequelae of SARS-CoV-2 infection T Thaweethai, SE Jolley, EW Karlson, EB Levitan, B Levy, GA McComsey, ... Jama 329 (22), 1934-1946, 2023 | 578 | 2023 |
| Measuring progress from 1990 to 2017 and projecting attainment to 2030 of the health-related Sustainable Development Goals for 195 countries and territories: a systematic … R Lozano, N Fullman, D Abate, SM Abay, C Abbafati, N Abbasi, ... The lancet 392 (10159), 2091-2138, 2018 | 547 | 2018 |
| AMPK dysregulation promotes diabetes-related reduction of superoxide and mitochondrial function LL Dugan, YH You, SS Ali, M Diamond-Stanic, S Miyamoto, AE DeCleves, ... The Journal of clinical investigation 123 (11), 2013 | 494 | 2013 |
| Renal sodium–glucose transport: role in diabetes mellitus and potential clinical implications GL Bakris, VA Fonseca, K Sharma, EM Wright Kidney international 75 (12), 1272-1277, 2009 | 478 | 2009 |
| Mechanisms linking obesity, chronic kidney disease, and fatty liver disease: the roles of fetuin-A, adiponectin, and AMPK JH Ix, K Sharma Journal of the American Society of Nephrology 21 (3), 406-412, 2010 | 460 | 2010 |
| High glucose-induced proliferation in mesangial cells is reversed by autocrine TGF-β G Wolf, K Sharma, Y Chen, M Ericksen, FN Ziyadeh Kidney international 42 (3), 647-656, 1992 | 442 | 1992 |
| Knockout of Na-glucose transporter SGLT2 attenuates hyperglycemia and glomerular hyperfiltration but not kidney growth or injury in diabetes mellitus V Vallon, M Rose, M Gerasimova, J Satriano, KA Platt, H Koepsell, ... American Journal of Physiology-Renal Physiology 304 (2), F156-F167, 2013 | 420 | 2013 |
